COMMUNIQUÉS West-GlobeNewswire

LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)

21/02/2018 - 22:06

BURLINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27 [...]

Atara Biotherapeutics Announces Chief Financial Officer Intention to Retire in April 2018

21/02/2018 - 22:06

Launches Search for Chief Financial Officer SOUTH SAN FRANCISCO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing [...]

TRACON to Report Fourth Quarter and Full Year 2017 Company Highlights and Financial Results on February 28, 2018

21/02/2018 - 22:05

SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

GenMark Diagnostics to Present at Upcoming Investor Conferences

21/02/2018 - 22:03

CARLSBAD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) today announced that the Company plans to participate in two upcoming investor conferences. March 1, 2018, GenMark’s [...]

G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights

21/02/2018 - 22:01

Topline data expected in March 2018 from first of three ongoing Phase 2 trials evaluating the myelopreservation benefits of trilaciclib Management to host webcast and conference call today at 4:30 p.m. EST RESEARCH [...]

GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006

21/02/2018 - 22:01

-Study did not meet its primary endpoint- -Company remains committed to continued development of GWP42006 for autism spectrum disorders and will continue to explore the product’s potential within the field of epilepsy- [...]

Achaogen Announces New Employment Inducement Grants

21/02/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Cerner Implements Surescripts Prescription Price Transparency Functionality Within the EHR

21/02/2018 - 22:01

KANSAS CITY, Mo., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, is collaborating with Surescripts to integrate their Real-Time Prescription Benefit functionality into the Cerner [...]

PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance

21/02/2018 - 22:00

Net new business of $647.3 million in the fourth quarter; Net book-to-bill of 1.30 $568.8 million of service revenue in the fourth quarter; 37.5% actual growth and 20.2% organic growth at actual foreign exchange rates [...]

Taconic Biosciences Announces the Formation of Scientific Advisory Board

21/02/2018 - 19:03

RENSSELAER, N.Y., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) [...]

Nextech’s 2018 EDGE User Conference Brings Together Medical Specialty Professionals for Expansive Knowledge Exchange

21/02/2018 - 18:53

TAMPA, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will host its fourth annual user conference, EDGE, February 22- [...]

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

21/02/2018 - 17:09

SAN ANTONIO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition [...]

Genmab 2017 Annual Report

21/02/2018 - 17:02

Company Announcement Copenhagen, Denmark; February 21, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017. Below is a summary of business progress and financial performance for the [...]

Orange County Plastic Surgeon Recognized as OCMA Physician of Excellence and Orange Coast Magazine Top Doctor

21/02/2018 - 17:01

NEWPORT BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- For the second time, Dr. Semira Bayati, a plastic surgeon in Newport Beach , has been recognized as a Physician of Excellence by the Orange County Medical [...]

Provant Health Chief Information Officer Discusses CIO Roles

21/02/2018 - 16:30

EAST GREENWICH, R.I., Feb. 21, 2018 (GLOBE NEWSWIRE) -- In his CIO Applications article on the CIO Hall of Faces , Tom Basiliere, chief information officer for Provant Health, discusses today’s evolving CIO roles. [...]

Aino Health AB (publ): signs contract with Region Västmanland

21/02/2018 - 16:01

Region Västmanland and Aino Health Sweden AB have signed a contract on a health audit of the region's operations. The project, pursued jointly by Region Västmanland and Aino Health, encompasses a mapping of the current [...]

Dynavax’s HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults

21/02/2018 - 15:36

BERKELEY, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization [...]

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells

21/02/2018 - 15:30

VANCOUVER, British Columbia and SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today announced the Company has discovered certain cannabinoids that enhance the [...]

Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic

21/02/2018 - 15:04

PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S. Food and Drug [...]